SCHEMBL6192104

SCHEMBL6192104

Nc1nc(Nc2ccc(S(=O)(=O)NCCCN3CCCC3)cc2)sc1C(=O)c1c(F)cccc1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 7/20 0.58
CDK4 P11802 7/20 0.58
CCND1 P24385 7/20 0.58
CDK9 P50750 7/20 0.58
CDK6 Q00534 7/20 0.58
CDK11A Q9UQ88 7/20 0.58
CCNA2 P20248 8/20 0.49
CDK2 P24941 8/20 0.49
SRC P12931 1/20 0.46
CDK5 Q00535 2/20 0.46
LTK P29376 1/20 0.46
CLK2 P49760 1/20 0.46
GSK3A P49840 1/20 0.46
GSK3B P49841 1/20 0.46
CDK7 P50613 1/20 0.46
LIMK1 P53667 1/20 0.46
PRKCQ Q04759 1/20 0.46
TAOK1 Q7L7X3 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
ALK Q9UM73 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208473 0.99 CCNT1 (0.57) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6193441 0.89 CCNT1 (0.55) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6195052 0.88 CDK11A (0.54) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6701026 0.86 CCNA2 (0.54) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6195665 0.85 CCNA2 (0.53) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6211465 0.85 CCNA2 (0.56) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6193477 0.84 CCNA2 (0.52) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6192807 0.84 CCNB2 (0.55) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6194186 0.84 CCNT1 (0.57) CCNT1CDK4CCND1CDK9CDK6
SCHEMBL6194606 0.83 CCNT1 (0.53) CCNT1CDK4CCND1CDK9CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594866-A1 ANTIPROLIFERATIVE 2-(SULFO-PHENYL)-AMINOTHIAZOLE DERIVATIVES PFIZER INC. (US) 2005-11-16 EP disclosed
US-20040176431-A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use PFIZER, INC. 2004-09-09 US disclosed
WO-2004072070-A1 ANTIPROLIFERATIVE 2-(SULFO-PHENYL)-AMINOTHIAZOLE DERIVATIVES PFIZER INC. (US) 2004-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176431-A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use MKI67, TK1, CDK2 CCNT1 7/4885CDK4 15/4885CCND1 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.